Terrace Biotech’s core technologies originate from lung research conducted at the University of California, San Francisco (UCSF) Medical Center, where early work helped define the properties of pulmonary surfactants and contributed to the development of synthetic surfactant therapies for premature infants with respiratory distress syndrome. Building on more than 25 years of expertise in pulmonary cell biology, Terrace Biotech applies its specialized knowledge to advance biomedical research and improve human health. The company’s antibodies are designed to specifically target alveolar epithelial type I and type II cells in the lung and are validated for reliable use in a wide range of applications.

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of Terrace Biotech products.

⇨ Inquire or Order immediately ⇦

1. Anti HT1-56

A lung-specific antibody targeting alveolar epithelial type I cells, suitable for applications such as immunohistochemistry (IHC), Western blotting, and cell identification studies.

2.Anti HT2-280

An antibody specific for alveolar epithelial type II cells, widely used in lung biology research, including cell characterization and functional studies.

3. Anti RT1-40

A validated antibody targeting alveolar epithelial type I cells, supporting applications such as flow cytometry (FACS), cell sorting, and imaging-based assays.

4. Anti RT2-70

An antibody designed for the detection of alveolar epithelial type II cells, suitable for use in multiple experimental workflows including immunostaining and cell-based analysis.

■ Product List